{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:14Z","timestamp":1791925394603,"version":"4.3.4"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.594782","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T04:01:22Z","timestamp":1604548882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Linking Immunoevasion and Metabolic Reprogramming in B-Cell\u2013Derived Lymphomas"],"prefix":"10.3389","volume":"10","author":[{"given":"Martin","family":"B\u00f6ttcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mackensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Mougiakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309","article-title":"On the Origin of Cancer Cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1242454","DOI":"10.1126\/science.1242454","article-title":"Fueling Immunity: Insights into Metabolism and Lymphocyte Function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053019","article-title":"Unraveling the Complex Interplay Between T Cell Metabolism and Function","volume":"36","author":"Geltink","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0230-9","article-title":"The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML","volume":"20","author":"Vetrie","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0032-5","article-title":"Targeting metabolism to regulate immune responses in autoimmunity and cancer","volume":"18","author":"Patel","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.3909","article-title":"A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin\u2019s Lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"New Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.08.014","article-title":"Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma","volume":"22","author":"Caro","year":"2012","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2017.10.002","article-title":"Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma","volume":"44","author":"Gooptu","year":"2017","journal-title":"Semin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-100115","article-title":"SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1713317","article-title":"Diffuse large B-cell lymphoma with low 18F-fluorodeoxyglucose avidity features silent B-cell receptor signaling","volume":"61","author":"Sheng","year":"2020","journal-title":"Leukemia Lymphoma"},{"key":"B17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jbior.2019.03.003","article-title":"Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship","volume":"72","author":"Jhanwar-Uniyal","year":"2019","journal-title":"Adv Biol Regul"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.141","article-title":"Activity and complexes of mTOR in diffuse large B-cell lymphomas\u2013a tissue microarray study","volume":"25","author":"Sebesty\u00e9n","year":"2012","journal-title":"Modern Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2003.11.003","article-title":"IDO and tolerance to tumors","volume":"10","author":"Munn","year":"2004","journal-title":"Trends Mol Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.celrep.2019.04.014","article-title":"Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation","volume":"27","author":"Sun","year":"2019","journal-title":"Cell Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1093-z","article-title":"Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"90","author":"Ninomiya","year":"2011","journal-title":"Ann Hematol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01393.x","article-title":"Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"84","author":"Yoshikawa","year":"2010","journal-title":"Eur J Haematol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-026203","article-title":"Syk-dependent mTOR activation in follicular lymphoma cells","volume":"108","author":"Leseux","year":"2006","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2016","journal-title":"Nat Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0098-8","article-title":"Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR","volume":"1","author":"Ortega-Molina","year":"2019","journal-title":"Nat Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1038\/bcj.2015.18","article-title":"Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma","volume":"5","author":"Ludvigsen","year":"2015","journal-title":"Blood Cancer J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0233449","DOI":"10.1371\/journal.pone.0233449","article-title":"Glycolytic biomarkers predict transformation in patients with follicular lymphoma","volume":"15","author":"Monrad","year":"2020","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.226","article-title":"A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma","volume":"25","author":"Witzig","year":"2011","journal-title":"Leukemia"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma","volume":"108","author":"Rudelius","year":"2006","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16602","article-title":"Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1","volume":"8","author":"Sekihara","year":"2017","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.7977","article-title":"Phase III study to evaluate temsirolimus compared with investigator\u2019s choice therapy for the treatment of relapsed or refractory mantle cell lymphoma","volume":"27","author":"Hess","year":"2009","journal-title":"J Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-18-0256","article-title":"Metabolic Detection of Bruton\u2019s Tyrosine Kinase Inhibition in Mantle Cell Lymphoma Cells","volume":"17","author":"Lee","year":"2019","journal-title":"Mol Cancer Res MCR"},{"key":"B34","doi-asserted-by":"publisher","first-page":"eaau1167","DOI":"10.1126\/scitranslmed.aau1167","article-title":"Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma","volume":"11","author":"Zhang","year":"2019","journal-title":"Sci Trans Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"New Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/leu.2015.187","article-title":"Metabolic plasticity in CLL: adaptation to the hypoxic niche","volume":"30","author":"Koczula","year":"2016","journal-title":"Leukemia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/bloodadvances.2016000984","article-title":"Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment","volume":"1","author":"Serra","year":"2016","journal-title":"Blood Adv"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403545","article-title":"Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine","volume":"18","author":"Carew","year":"2004","journal-title":"Leukemia"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079368","article-title":"Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide","volume":"299","author":"Nisoli","year":"2003","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-532200","article-title":"Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia","volume":"123","author":"Jitschin","year":"2014","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-17-0026","article-title":"B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia","volume":"15","author":"Vangapandu","year":"2017","journal-title":"Mol Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.203067","article-title":"Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity","volume":"104","author":"Lu","year":"2019","journal-title":"Haematologica"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-607036","article-title":"Stromal cell\u2013mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling","volume":"125","author":"Jitschin","year":"2015","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403748","article-title":"High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia","volume":"19","author":"Heintel","year":"2005","journal-title":"Leukemia"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-14-0412","article-title":"Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells","volume":"13","author":"Rozovski","year":"2015","journal-title":"Mol Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2015.06.010","article-title":"Mitochondrial free fatty acid \u03b2-oxidation supports oxidative phosphorylation and proliferation in cancer cells","volume":"65","author":"Rodr\u00edguez-Enr\u00edquez","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0704024104","article-title":"Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle","volume":"104","author":"Garcia-Roves","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25066","article-title":"STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells","volume":"9","author":"Rozovski","year":"2018","journal-title":"Oncotarget"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2018.1439167","article-title":"Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia","volume":"59","author":"Rozovski","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00411","article-title":"Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes","volume":"8","author":"Galicia-Vazquez","year":"2018","journal-title":"Front Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cmet.2019.02.002","article-title":"GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors","volume":"29","author":"Chiche","year":"2019","journal-title":"Cell Metab"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1038\/s41467-019-10015-4","article-title":"Competition for nutrients and its role in controlling immune responses","volume":"10","author":"Kedia-Mehta","year":"2019","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O\u2019Neill","year":"2015","journal-title":"J Exp Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0282-0","article-title":"The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells","volume":"559","author":"Borges da Silva","year":"2018","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of\u2009 T Cell Proliferation by Macrophage Tryptophan Catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J Exp Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21716","article-title":"IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan","volume":"1","author":"Metz","year":"2012","journal-title":"OncoImmunology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2556","article-title":"Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation","volume":"14","author":"Sinclair","year":"2013","journal-title":"Nat Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell\u2013derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-Repopulating Cells Induce PD-1 Expression in CD8(+) T Cells by Transferring Kynurenine and AhR Activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"B64","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/s41598-019-48635-x","article-title":"Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma","volume":"9","author":"Rad Pour","year":"2019","journal-title":"Sci Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function","volume":"108","author":"Chiesa","year":"2006","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0018","article-title":"Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity","volume":"3","author":"Bastid","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206184","article-title":"Adenosine suppresses activation of nuclear factor-\u03baB selectively induced by tumor necrosis factor in different cell types","volume":"22","author":"Majumdar","year":"2003","journal-title":"Oncogene"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03075.x","article-title":"Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling","volume":"128","author":"Linnemann","year":"2009","journal-title":"Immunology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s40425-019-0719-5","article-title":"Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells","volume":"7","author":"Mastelic-Gavillet","year":"2019","journal-title":"J ImmunoTher Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"4093214","DOI":"10.1155\/2019\/4093214","article-title":"Adenosine Generated by Regulatory T Cells Induces CD8+ T Cell Exhaustion in Gastric Cancer through A2aR Pathway","volume":"2019","author":"Shi","year":"2019","journal-title":"BioMed Res Int"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2826","article-title":"A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment","volume":"78","author":"Young","year":"2018","journal-title":"Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2007.05.004","article-title":"Oxidative stress modulation and T cell activation","volume":"42","author":"Larbi","year":"2007","journal-title":"Exp Gerontol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.5.1961.h8001961_1961_1968","article-title":"Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine","volume":"96","author":"Mellqvist","year":"2000","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.23.13119","article-title":"Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses","volume":"93","author":"Otsuji","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.2.400-411.2002","article-title":"Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways","volume":"22","author":"Gringhuis","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2595","article-title":"Inhibition of Activated\/Memory (CD45RO+) T Cells by Oxidative Stress Associated with Block of NF-\u03baB Activation","volume":"167","author":"Malmberg","year":"2001","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2162-3619-1-2","article-title":"Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma","volume":"1","author":"Peroja","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.1787.1787","article-title":"Oxidative Stress Is Associated with Poor Prognosis in Patients with Follicular Lymphoma","volume":"128","author":"Arakaki","year":"2016","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-307041","article-title":"Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress","volume":"117","author":"Mougiakakos","year":"2011","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Kiyasu","year":"2015","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1182\/blood-2017-07-740993","article-title":"PD-1 expression and clinical PD-1 blockade in B-cell lymphomas","volume":"131","author":"Xu-Monette","year":"2018","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00632","article-title":"Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion","volume":"8","author":"Xia","year":"2018","journal-title":"Front Oncol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"12632","DOI":"10.1038\/ncomms12632","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity","volume":"7","author":"Li","year":"2016","journal-title":"Nat Commun"},{"key":"B87","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","article-title":"mTOR, metabolism, and the regulation of T-cell differentiation and function","volume":"249","author":"Waickman","year":"2012","journal-title":"Immunological Rev"},{"key":"B88","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13045-016-0343-5","article-title":"Targeting of PI3K\/AKT\/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development","volume":"9","author":"Herrero-S\u00e1nchez","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40425-015-0094-9","article-title":"Targeting the indoleamine 2,3-dioxygenase pathway in cancer","volume":"3","author":"Moon","year":"2015","journal-title":"J Immunother Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood-2005-10-4073","article-title":"Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial","volume":"108","author":"Brune","year":"2006","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1743","article-title":"Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy","volume":"76","author":"Pilon-Thomas","year":"2016","journal-title":"Cancer Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00849","article-title":"CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences","volume":"10","author":"Vitale","year":"2020","journal-title":"Front Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621474","article-title":"Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs","volume":"125","author":"Ninomiya","year":"2015","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00322","article-title":"A Metabolism Toolbox for CAR T Therapy","volume":"9","author":"Xu","year":"2019","journal-title":"Front Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3843","article-title":"Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies","volume":"71","author":"Singh","year":"2011","journal-title":"Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1172\/JCI89455","article-title":"Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy","volume":"127","author":"Beavis","year":"2017","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.594782\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T04:01:24Z","timestamp":1604548884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.594782\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":96,"alternative-id":["10.3389\/fonc.2020.594782"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.594782","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"article-number":"594782"}}